Stopping Prometrium: What the Discontinuation Study Found
Stopping Prometrium can mean ending progesterone-only treatment, ending both components of menopausal hormone therapy, or removing progesterone while estrogen continues. Those decisions have different consequences. The current brand label covers endometrial protection with conjugated estrogen and treatment of secondary amenorrhea; it does not provide a universal discontinuation or taper protocol. [1]
Symptom return is different from rebound
The stopping report involved 34 participants: 17 had received progesterone and 17 placebo. Hot flashes and night sweats gradually returned; the progesterone group's symptom number was 78% of pretreatment baseline at week four. An increase above baseline, the rebound outcome assessed, was not observed in this selected subgroup. [2]
The parent randomized trial involved 133 healthy, early postmenopausal women, one to ten years after their final menstrual period. It tested nightly oral progesterone for 12 weeks and found treatment benefit for vasomotor symptoms. This is the same parent cohort, not independent confirmation of the discontinuation findings. Neither report establishes outcomes for every long-term user of other prescribed regimens. [3]
What each evidence source actually tested
| Evidence | What was measured | What it does not establish |
|---|---|---|
| Progesterone withdrawal substudy | One-month vasomotor follow-up; no observed increase above pretreatment baseline. [2] | A comprehensive withdrawal syndrome or outcomes for all doses and durations. |
| Progesterone sleep review | Nine randomized trials with 388 participants; pooled results favored sleep latency, but not total sleep time or sleep efficiency. [4] | A predictable onset or duration of insomnia after stopping. |
| Combined-HRT stopping trial | Eighty-one women randomized to taper or stop abruptly; no differences in hot flashes, quality of life, or resumption through 12 months. [5] | A Prometrium-only taper comparison or proof that tapering never helps an individual. |
Sleep changes need their own assessment
Sleep-treatment evidence cannot establish a withdrawal timetable. Individual trials in the review were inconsistent, and accompanying estrogen treatment or improvements in hot flashes limited interpretation. Progesterone-metabolite effects on GABA-A receptors provide biological context, not a validated prediction of anxiety or insomnia after discontinuation. New or persistent difficulties deserve review of the actual medication change and other possible contributors. [4]
Decide what happens to estrogen and uterine protection
If systemic estrogen continues and you have a uterus, adequate endometrial protection generally remains necessary. That usually means a progestogen, although specific protective combinations are alternatives. After hysterectomy, the purpose of progesterone may differ; the original indication still matters. [6]
The PEPI endometrial trial illustrates why this distinction matters. Over three years, conjugated estrogen alone increased endometrial hyperplasia, while the tested estrogen–progestogen combinations had rates similar to placebo. It does not establish safety after removing progesterone or guarantee protection with every estrogen preparation. [9]
For stopping HRT overall, NICE offers a choice between gradual and immediate cessation: tapering may reduce short-term recurrence, without a long-term symptom difference. The Menopause Society notes limited evidence and general expert preference for gradual reductions. These positions do not supply a capsule-by-capsule Prometrium taper. [6][7]
Keep scheduled breaks separate from stopping treatment
A planned cyclic break belongs to a specific prescription; it is not permission to progressively omit capsules. Expected cyclic bleeding also differs from new unscheduled bleeding. Assessment depends on the regimen, timing, intensity, persistence, and individual risk factors. New postmenopausal, persistent, or heavy bleeding should not simply be attributed to withdrawal. [1][8]
For review, record the indication, current estrogen treatment, progesterone schedule, last actual dose, what changed, and dated symptoms or bleeding. Bring this record to the appointment so the plan addresses your actual regimen.
Frequently asked questions
What are the most common rebound effects after stopping Prometrium?
The stopping report measured vasomotor symptoms; it does not establish a ranked list of withdrawal effects. [2] Describe the actual symptom and what else changed instead of relying on a predicted sequence.
How long do Prometrium withdrawal symptoms last?
The report's four-week observation is not a universal recovery duration. [2] Record when a symptom started, whether it is persisting and what medication changes accompanied it.
Can stopping Prometrium cause anxiety?
The available sleep review does not establish the frequency or timing of anxiety after stopping. Progesterone-metabolite effects on GABA-A receptors cannot supply that prediction. Review new or persistent anxiety alongside the exact treatment change and other contributors. [4]
Does stopping Prometrium affect sleep?
Sleep may change, but treatment studies do not establish a predictable discontinuation effect. A review found some benefit for falling asleep, with inconsistent other outcomes. Persistent sleep difficulty warrants review rather than an assumed withdrawal timetable. [4]
Will stopping Prometrium cause hot flashes?
Hot flashes can return as treatment benefit fades. In this selected subgroup, the increase stayed below pretreatment baseline at week four. [2] The parent trial demonstrated benefit during treatment. [3]
Is it safe to stop Prometrium cold turkey?
First establish why you take it and whether estrogen will continue. NICE permits immediate or gradual HRT cessation, but that is not blanket permission to remove uterine protection. The label supplies no universal Prometrium stopping protocol. [1][7]
Can I stop Prometrium and keep taking estrogen?
If you have a uterus and continue systemic estrogen, adequate endometrial protection generally remains necessary through a progestogen or specific protective alternative. After hysterectomy, the context often differs, but your original progesterone indication still needs review. [6][9]
What is the difference between Prometrium and Provera withdrawal?
Prometrium contains micronized progesterone; Provera contains medroxyprogesterone acetate. They are distinct progestogens used in different regimens. The cited evidence does not directly compare withdrawal-syndrome severity between them, so it cannot establish that one produces easier discontinuation. [1][9]
How do I taper off Prometrium 200 mg?
These sources do not provide a universal 200 mg taper sequence. First clarify the indication, prescribed schedule, and continued estrogen or endometrial-protection plan. General HRT guidance supports discussing gradual or immediate cessation, not improvising capsule omissions. [1][7]
Can stopping progesterone cause weight gain?
The stopping report does not establish a weight-change frequency or timeline. [2] Record measured weight and other treatment or lifestyle changes rather than assuming a predictable fluid reset.
Does stopping Prometrium cause bleeding?
Withdrawal bleeding can occur in prescribed contexts, but the label's amenorrhea-treatment findings do not predict every HRT user's bleeding. Distinguish expected cyclic bleeding from new unscheduled bleeding; persistent, heavy, or new postmenopausal bleeding needs assessment. [1][8]
What does the Menopause Society say about stopping HRT?
Its 2022 statement notes limited evidence on optimal discontinuation and general expert advice favoring gradual reductions. NICE offers gradual or immediate stopping, with possible short-term benefit from tapering but no long-term symptom difference. Neither supplies a Prometrium-specific schedule. [6][7]
References
Sources checked October 14, 2026.
- PROMETRIUM prescribing information, revised February 2026.
- Prior JC, Hitchcock CL. Progesterone discontinuation and vasomotor symptoms: withdrawal report, 2012.
- Hitchcock CL, Prior JC. Oral micronized progesterone for vasomotor symptoms: randomized trial, 2012.
- Nolan BJ et al. Efficacy of micronized progesterone for sleep: systematic review and meta-analysis, 2021.
- Lindh-Åstrand L et al. Taper-down or abrupt discontinuation of hormone therapy: randomized trial, 2010.
- The North American Menopause Society. The 2022 hormone therapy position statement.
- NICE NG23. Menopause: identification and management—recommendations.
- British Menopause Society. Management of unscheduled bleeding on hormone replacement therapy.
- PEPI Trial Writing Group. Effects of hormone replacement therapy on endometrial histology, 1996.
